(Q33753722)

English

Assessing feasibility, compliance and toxicity of concomitant chemo-radiotherapy in head and neck cancers in the Northern Territory: initial experience and challenges

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Assessing feasibility, compliance and toxicity of concomitant chemo-radiotherapy in head and neck cancers in the Northern Territory: initial experience and challenges (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Ajay Gupta

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Siddhartha Baxi

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Christopher Hoyne

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 July 2016

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Journal of medical radiation sciences

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

131-137

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5454327

28 July 2018

Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5454327

28 July 2018

Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5454327

28 July 2018

Evaluation of early and late toxicities in chemoradiation trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5454327

28 July 2018

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5454327

28 July 2018

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5454327

28 July 2018

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5454327

28 July 2018

Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.

1 reference

https://api.crossref.org/works/10.1002%2FJMRS.183

21 January 2018

Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FJMRS.183

21 January 2018

Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FJMRS.183

21 January 2018

Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.

1 reference

https://api.crossref.org/works/10.1002%2FJMRS.183

21 January 2018

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

1 reference

https://api.crossref.org/works/10.1002%2FJMRS.183

21 January 2018

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJMRS.183

21 January 2018

Radiation treatment compliance in the Indigenous population: the pilot Northern Territory experience and future directions.

1 reference

https://api.crossref.org/works/10.1002%2FJMRS.183

21 January 2018

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5454327

30 October 2018

Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/27741378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/27741378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for strongyloidiasis hyperinfection and clinical outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/27741378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/27741378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27741378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/JMRS.183

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33753722&oldid=1952409886"